Cell Death and Disease (Dec 2023)

The TRIM21-FOXD1-BCL-2 axis underlies hyperglycaemic cell death and diabetic tissue damage

  • Wenwen Cheng,
  • Cifeng Cai,
  • Yifan Xu,
  • Xueqi Xiao,
  • Tiantian Shi,
  • Yueling Liao,
  • Xiaoyi Wang,
  • Shasha Chen,
  • Meiliang Zhou,
  • Zhiyong Liao

DOI
https://doi.org/10.1038/s41419-023-06355-1
Journal volume & issue
Vol. 14, no. 12
pp. 1 – 14

Abstract

Read online

Abstract Chronic hyperglycaemia is a devastating factor that causes diabetes-induced damage to the retina and kidney. However, the precise mechanism by which hyperglycaemia drives apoptotic cell death is incompletely known. Herein, we found that FOXD1, a FOX family transcription factor specifically expressed in the retina and kidney, regulated the transcription of BCL-2, a master regulator of cell survival. Intriguingly, the protein level of FOXD1, which responded negatively to hyperglycaemic conditions, was controlled by the TRIM21-mediated K48-linked polyubiquitination and subsequent proteasomal degradation. The TRIM21-FOXD1-BCL-2 signalling axis was notably active during diabetes-induced damage to murine retinal and renal tissues. Furthermore, we found that tartary buckwheat flavonoids effectively reversed the downregulation of FOXD1 protein expression and thus restored BCL-2 expression and facilitated the survival of retinal and renal tissues. In summary, we identified a transcription factor responsible for BCL-2 expression, a signalling axis (TRM21-FOXD1-BCL-2) underlying hyperglycaemia-triggered apoptosis, and a potential treatment for deleterious diabetic complications.